The Future of
The Future of
The Future of
Regenerative Medicine
Regenerative Medicine
Regenerative Medicine
We develop neonatal plasma-based medicines to reverse age-related decline.
We develop neonatal plasma-based medicines to reverse age-related decline.
Nu is developing medicines derived from neonatal plasma to reverse age-related decline.
Nu is developing medicines derived from neonatal plasma to reverse age-related decline.
Nu is developing medicines derived from neonatal plasma to reverse age-related decline.
Our mission is to restore the body’s natural ability to repair itself — starting with the heart, and extending to broader healthspan and longevity.
Aging is the single greatest risk factor for cardiovascular disease and many other conditions.
Current therapies save lives but fail to restore full function, especially in older patients.
Nu’s approach is different: we isolate and validate pro-youthful factors from neonatal plasma, applying them to regenerate tissues, reduce inflammation, and reverse hallmarks of aging.
We begin with the heart — but our vision extends across organs and systems, from brain to muscle to metabolism.
Our mission is to restore the body’s natural ability to repair itself — starting with the heart, and extending to broader healthspan and longevity.
Aging is the single greatest risk factor for cardiovascular disease and many other conditions.
Current therapies save lives but fail to restore full function, especially in older patients.
Nu’s approach is different: we isolate and validate pro-youthful factors from neonatal plasma, applying them to regenerate tissues, reduce inflammation, and reverse hallmarks of aging.
We begin with the heart — but our vision extends across organs and systems, from brain to muscle to metabolism.
Our mission is to restore the body’s natural ability to repair itself — starting with the heart, and extending to broader healthspan and longevity.
Aging is the single greatest risk factor for cardiovascular disease and many other conditions.
Current therapies save lives but fail to restore full function, especially in older patients.
Nu’s approach is different: we isolate and validate pro-youthful factors from neonatal plasma, applying them to regenerate tissues, reduce inflammation, and reverse hallmarks of aging.
We begin with the heart — but our vision extends across organs and systems, from brain to muscle to metabolism.
FAQ
FAQ
What is Nu developing?
Nu is creating therapeutics derived from neonatal plasma, enriched with pro-youthful factors that promote regeneration and reverse age-related decline. Our first focus is restoring heart function after myocardial infarction (heart attack).
How does it work?
What evidence supports this approach?
How is Nu different from past “young blood” studies?
What are the potential applications beyond the heart?
What is Nu developing?
Nu is creating therapeutics derived from neonatal plasma, enriched with pro-youthful factors that promote regeneration and reverse age-related decline. Our first focus is restoring heart function after myocardial infarction (heart attack).
How does it work?
What evidence supports this approach?
How is Nu different from past “young blood” studies?
What are the potential applications beyond the heart?
What is Nu developing?
Nu is creating therapeutics derived from neonatal plasma, enriched with pro-youthful factors that promote regeneration and reverse age-related decline. Our first focus is restoring heart function after myocardial infarction (heart attack).
How does it work?
What evidence supports this approach?
How is Nu different from past “young blood” studies?
What are the potential applications beyond the heart?
